Lilly announced that 3mL (300-unit) vials of Humalog (insulin lispro [recombinant]) and Humulin R U-100 (regular insulin [human, recombinant]) will be made available to hospitals in January 2010. Based on the average length of stay in the hospital for patients with diabetes, this smaller insulin vial size was developed to provide hospitals more flexibility when evaluating insulin storage, delivery, and distribution options.

Lilly will continue to supply the traditional 10mL (1000-unit) insulin vial sizes as well as its pre-filled pen injection devices.

For more information call (800) 545-5979 or visit www.lilly.com.